SYS-CON MEDIA Authors: Yeshim Deniz, Doug Masi, Mat Mathews, Newswire, David Smith

News Feed Item

Pinney Associates' Jack Henningfield to Address Abuse Liability Tamper Testing as a Foundation for Drug Scheduling

BETHESDA, Md., Feb. 18, 2014 /PRNewswire/ -- Jack E. Henningfield, PhD, Vice President for Research and Health Policy at Pinney Associates, will address the science of abuse liability tamper testing of controlled substances during a February 19 roundtable session at The Food and Drug Law Institute 2014 Controlled Substances Regulation Conference in Washington, DC.

Pinney Associates logo

"Rigorous testing of formulation, extraction, and tampering offers sponsors a place to discuss appropriate scheduling of novel molecules and formulations of controlled substances with regulators," said Dr. Jack Henningfield.  "Sponsors must anticipate and respond to the regulatory expectations for tamper testing and abuse liability assessment within the context of the evolving science and FDA guidance."

See more about the meeting, registration, and the full agenda at:

Pinney Associates' scientists include internationally respected leaders in the evolving science of in vitro assessment of abuse-deterrent drugs and formulations (commonly referred to as "tamper testing") and drug abuse liability assessment.  Through our collaborations, we offer comprehensive in vitro assessment on abuse-deterrence and tamper resistance, animal and human abuse liability assessment related services.

For more about Pinney Associates, please visit our website:


SOURCE Pinney Associates

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.